Janus Henderson Group’s Clover Health Investments CLOV Stock Holding History

Janus Henderson Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$297K	Hold	169,300	–	–	﹤0.01%	2220
2025 Q4	$397K	Hold	169,300	–	–	﹤0.01%	2105
2025 Q3	$519K	Hold	169,300	–	–	﹤0.01%	1983
2025 Q2	$472K	Hold	169,300	–	–	﹤0.01%	1988
2025 Q1	$609K	Hold	169,300	–	–	﹤0.01%	1859
2024 Q4	$532K	Hold	169,300	–	–	﹤0.01%	2002
2024 Q3	$477K	Buy	+169,300	New	+$388K	﹤0.01%	2060
2024 Q2	–	Sell	-138,819	Closed	-$109K	–	2535
2024 Q1	$109K	Buy	138,819 +19	+0%	+$17	﹤0.01%	2506
2023 Q4	$132K	Sell	138,800 -70	-0.1%	-$69	﹤0.01%	2504
2023 Q3	$151K	Buy	138,870 +29	+0%	+$35	﹤0.01%	2450
2023 Q2	$124K	Sell	138,841 -689,438	-83%	-$612K	﹤0.01%	2550
2023 Q1	$700K	Buy	828,279 +764,436	+1,197%	+$837K	﹤0.01%	1832
2022 Q4	$59.2K	Sell	63,843 -63,839	-50%	-$85.2K	﹤0.01%	2404
2022 Q3	$218K	Buy	127,682 +63,752	+100%	+$167K	﹤0.01%	2366
2022 Q2	$137K	Buy	63,930 +384	+0.6%	+$1.02K	﹤0.01%	2415
2022 Q1	$226K	Buy	+63,546	New	+$184K	﹤0.01%	2378

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group's CLOV Position: Q1 2026 in Review

Janus Henderson Group held its Clover Health Investments (CLOV) position steady in Q1 2026 at 169,300 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Janus Henderson Group first reported a position in CLOV in Q1 2022 and has held it in 16 quarters since. The position peaked at $700K in Q1 2023. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

Janus Henderson Group held 169,300 shares of Clover Health Investments worth $297K as of Q1 2026.
Janus Henderson Group left its Clover Health Investments share count unchanged in Q1 2026.
Clover Health Investments made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2220 holding.
Janus Henderson Group first reported a position in Clover Health Investments in Q1 2022 and has held it in 16 quarters since.
Janus Henderson Group's Clover Health Investments position peaked at $700K in Q1 2023.
208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.